Ocugen, Inc. (OCGN)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1.2000 |
| Open | 1.2100 |
| Bid | 1.1900 x 1100 |
| Ask | 1.2200 x 1100 |
| Day's range | 1.1800 - 1.2300 |
| 52-week range | 0.3450 - 2.1050 |
| Volume | |
| Avg. volume | 5,483,112 |
| Market cap | 348.308M |
| Beta (5Y monthly) | 3.73 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Ocugen to Begin Phase III Study on Eye Drug in Canada, Stock Up
OCGN receives Health Canada's No Objection Letter to begin a phase III study on OCU400 for treating retinitis pigmentosa. Shares rise.
- Associated Press Finance
Ocugen: Q2 Earnings Snapshot
MALVERN, Pa. AP) — Ocugen, Inc. OCGN) on Thursday reported a loss of $15.3 million in its second quarter.
© 2024 Yahoo. All rights reserved.